Olema Pharmaceuticals (OLMA) Non Operating Income (2020 - 2026)
Olema Pharmaceuticals (OLMA) reported Non Operating Income of $4.9 million for Q1 2026, up 9.21% year-over-year from $4.5 million in Q1 2025, and up 21.73% quarter-over-quarter from $4.0 million in Q4 2025.
Olema Pharmaceuticals (OLMA) Non Operating Income (2020 - 2026) Analysis & Trends
Olema Pharmaceuticals (OLMA) has 7 years of Non Operating Income data on file, last reported at $4.9 million in Q1 2026.
- Non Operating Income for Q1 2026 came in at $4.9 million, up 9.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.7 million (up 19.86% YoY), and the FY2025 annual result was $16.2 million, up 27.09% from the prior year.
- Non Operating Income grew to $4.9 million in Q1 2026 per OLMA's latest filing, from $4.0 million in the prior quarter.
- Over five years, Non Operating Income peaked at $4.9 million in Q1 2026 and troughed at $224000.0 in Q1 2022.
- A 5-year average of $2.6 million and a median of $3.1 million in 2024 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2022 and 2024: Non Operating Income surged 924.49% in 2022, then slipped 12.16% in 2024.
- A 5-year view of Non Operating Income shows it stood at $1.0 million in 2022, then jumped by 250.38% to $3.6 million in 2023, then fell by 12.16% to $3.2 million in 2024, then grew by 25.68% to $4.0 million in 2025, then increased by 21.73% to $4.9 million in 2026.
- Business Quant data shows OLMA's Non Operating Income at $4.9 million in Q1 2026, $4.0 million in Q4 2025, and $3.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 9.35 Mn |
| 10 | Olema Pharmaceuticals | 1.01 Bn | 1.01 Bn | - | 4.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.90 Mn |
| Dec 31, 2025 | 4.02 Mn |
| Sep 30, 2025 | 3.66 Mn |
| Jun 30, 2025 | 4.08 Mn |
| Mar 31, 2025 | 4.48 Mn |
| Dec 31, 2024 | 3.20 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | 3.15 Mn |
| Mar 31, 2024 | 3.37 Mn |
| Dec 31, 2023 | 3.64 Mn |
| Sep 30, 2023 | 1.84 Mn |
| Jun 30, 2023 | 1.51 Mn |
| Mar 31, 2023 | 1.32 Mn |
| Dec 31, 2022 | 1.04 Mn |
| Sep 30, 2022 | 502,000.00 |
| Jun 30, 2022 | 435,000.00 |
| Mar 31, 2022 | 224,000.00 |
| Dec 31, 2021 | 119,000.00 |
| Sep 30, 2021 | 49,000.00 |
| Jun 30, 2021 | 116,000.00 |